Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure
Top Cited Papers
- 1 September 2001
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 158 (1), 195-198
- https://doi.org/10.1016/s0021-9150(01)00412-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Why a pomegranate?BMJ, 2000
- Treatment of hypertension with ascorbic acidThe Lancet, 1999
- Antioxidants for hypertensionCurrent Opinion in Nephrology and Hypertension, 1998
- Quantitative determination of the polyphenolic content of pomegranate peelZeitschrift für Lebensmittel-Untersuchung und Forschung, 1996
- Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage—foam cell accumulation independently of blood pressure and plasma lipidsAtherosclerosis, 1994
- Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin IIAtherosclerosis, 1994
- Aorta viscoelasticity and arterial histopathology of atherosclerotic pigs treated by angiotensin converting enzyme inhibitionJournal Of Hypertension, 1991
- Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with HypertensionNew England Journal of Medicine, 1991
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Angiotensin II Stimulation of Vascular Smooth MuscleJournal of Cardiovascular Pharmacology, 1989